In addition, PFS and OS were longer when gliomas expressed weak EGFRv1+vIII, -v2, v3, or -v4 mRNA levels and showed no mutant EGFRvIII mRNA expression (Table VI, Fig. 7B-F). The gene discussed is COX8A; the disease is central nervous system cancer.